Co-Diagnostics, Inc. Reports Third Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
Co-Diagnostics (CODX) Misses Q3 EPS by 10c
November 10, 2022 4:16 PM ESTCo-Diagnostics (NASDAQ: CODX) reported Q3 EPS of ($0.04), $0.10 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $5.1 million versus the consensus estimate of $15.33 million.
For earnings history and earnings-related data on Co-Diagnostics (CODX) click here.
... More